August 19, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

SAVE THE DATE!
NEXT SEMIANNUAL MEETING
#NRG20

January 9-11, 2020
Marriott Marquis - Houston, TX


AMENDMENTS

BREAST

NRG-BR003: Reminder Amendment 2; version date July 1, 2019. Activation instructions are posted under the Supplemental Documents tab on the NRG-BR003 page on the CTSU website.

GASTROINTESTINAL

NRG-GI004: Reminder Amendment 3; version date March 27, 2019. Activation instructions are posted under the Supplemental Documents tab on the NRG-GI004 page on the CTSU website.

GYNECOLOGIC

NRG GY005: Amendment 10; version date: July 16, 2019 (posted on CTSU)


FORM UPDATES

LUNG

NRG-LU005: revised Quality of Life forms have been posted to CTSU. Correct QOL forms can be accessed at these locations: 

  • NRG-LU005 > CIRB Documents > Amendment Reviews > Participant Questionnaire > Support Documents # 1-6 posted 8/9/2019
  • NRG-LU005 > CIRB Documents > Amendment Reviews > Participant Questionnaire > Support Documents #1-4 posted 6/10/2019
  • NRG-LU005 > CIRB Documents > Initial Reviews > Support Documents #12-13 posted 5/28/2019

 OTHER PROTOCOL NOTICES

1. AGCT1531: Children’s Oncology Group Protocol - “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial. Enrollment credited to NRG Oncology will count towards membership requirements.

 

 
2.   BRAIN

 NRG-BR002: The Kuhn-Hicks laboratory at USC will be closed August 21, 2019 to outside vendors (i.e. FedEx, UPS, etc) in preparation of students moving in for the new school year. Please reschedule all draws for Tuesday, August 20, due to our inability to receive samples on the 21st.

 

As an alternative, the lab will gladly accommodate and accept any blood samples as long as they are shipped to the following address:

 

FedEx Ship Center

 Attn: USC Kuhn-Hicks Laboratory

 3333 S. Grand Ave

 Los Angeles, CA 90007

 619-392-3553

 

For any question or concerns, please feel to reach out to kuhnlab@usc.edu or call 213-821-3051.

 

3. GYNECOLOGIC

NRG GY005: CEC Whole Blood Shipping Address memo (posted on CTSU)

 

NRG-GY009: Block Submission Reminder memo (posted on CTSU)

 

NRG-GY018: Kit Ordering memo (posted on CTSU)

 

Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more

 

4.  VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, September 11.

 

DRUG SAFETY UPDATES

Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Atezolimumab

NRG-BR004

NRG-GI004

NRG-GY009

NRG-GY017

NRG-LU005

CTSU

CTSU

CTSU

NRG

CTSU

Nivolumab

NRG-BN002

NRG

 

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Dauzier E, Lacas B, Blanchard P, Le QT, Simon C, Wolf G, Janot F, Horiuchi M, Tobias JS, Moon J, Simes J, Deshmane V, Mazeron JJ, Mehta S, Zaktonik B, Tamura M, Moyal E, Licitra L, Fortpied C, Haffty BG, Ghi MG, Gregoire V, Harris J, Bourhis J, Aupérin A, Pignon JP; MACH-NC Collaborative Group. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. Oral Oncol. 2019 Aug;95:106-114. doi: 10.1016/j.oraloncology.2019.06.001. Epub 2019 Jun 15. PubMed PMID: 31345376. Read More

Fuh KC, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS. Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients. Gynecol Oncol. 2019 Aug;154(2):420-425. doi: 10.1016/j.ygyno.2019.05.013. Epub 2019 Jun 19. PubMed PMID: 31229298. Read More

Spirtos NM, Enserro D, Homesley HD, Gibbons SK, Cella D, Morris RT, DeGeest K, Lee RB, Miller DS. The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study. Gynecol Oncol. 2019 Jul;154(1):13-21. doi: 10.1016/j.ygyno.2019.03.240. Epub 2019 Apr 30. PubMed PMID: 31053405. Read More

 

PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Society for Radiation Oncology (ASTRO); Sep 15-18, 201 9; Chicago, IL

International Gynecologic Cancer Society (IGCS); Sep 19-20, 2019; Rio de Janeiro, Brazil

International Society for Quality of Life Research (ISOQOL); Oct 20-23, 2019; San Diego, CA


Upcoming Abstract Submission Deadlines

American Society of Clinical Oncology (ASCO) GI; Jan 23-25, 2020; San Francisco, CA; due to publications committee Sep 17, 2019; meeting submission deadline Oct 1, 2019

European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain; LBA Aug 21, 2019 9pm CEST

San Antonio Breast Cancer Symposium (SABCS); Dec 10-14, 2019; San Antonio, TX; LBA Aug 30, 2019

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse